openPR Logo
Press release

Latest Angina Market Size, Share, Trend, Growth, Analysis and Forecast Report 2016 - Acute Market Reports

06-07-2016 09:57 AM CET | Health & Medicine

Press release from: Acute Market Reports

Latest Angina Market Size, Share, Trend, Growth, Analysis

Acute Market Reports, ‘Angina (Angina Pectoris) - Pipeline Review, H1 2016’, provides an overview of the Angina (Angina Pectoris) pipeline landscape.

Browse Full Report Visit - http://www.acutemarketreports.com/report/angina-angina-pectoris-pipeline-review-h1-2016

The report provides comprehensive information on the therapeutics under development for Angina (Angina Pectoris), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects.

Acute Market Reports features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Acute Market Reports proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the global therapeutic landscape of Angina (Angina Pectoris)
- The report reviews pipeline therapeutics for Angina (Angina Pectoris) by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Angina (Angina Pectoris) therapeutics and enlists all their major and minor projects
- The report assesses Angina (Angina Pectoris) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Angina (Angina Pectoris)
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Angina (Angina Pectoris)
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Angina (Angina Pectoris) pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Acute Market Reports Coverage 7
Angina (Angina Pectoris) Overview 8
Therapeutics Development 9
Pipeline Products for Angina (Angina Pectoris) - Overview 9
Pipeline Products for Angina (Angina Pectoris) - Comparative Analysis 10
Angina (Angina Pectoris) - Therapeutics under Development by Companies 11

About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Contact Us :
Chris Paul
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Latest Angina Market Size, Share, Trend, Growth, Analysis and Forecast Report 2016 - Acute Market Reports here

News-ID: 343595 • Views:

More Releases from Acute Market Reports

Pediatric Allergy Treatment Market Set to Soar: Projected to Reach $13.9 Billion by 2032 Amid Rising Allergy Prevalence and Advanced Therapeutic Development
Pediatric Allergy Treatment Market Set to Soar: Projected to Reach $13.9 Billion …
The pediatric allergy treatment market is experiencing significant growth, driven by the rising prevalence of allergic conditions among children. Allergies, including food allergies, allergic rhinitis, asthma, and skin allergies, are becoming increasingly common in the pediatric population. This trend has led to a growing demand for effective treatment options that can provide relief and improve the quality of life for children affected by these conditions. The market for pediatric allergy
Strippable Coatings Market Is Expected To Expand At A CAGR Of 7.1% From 2024 To …
Strippable coatings, also referred to as peelable coatings, are a type of non-flammable, water-based protective solution that can be easily removed from surfaces without the need for harsh chemical strippers or cleaners. Composed of water-based acrylic polymers, vapor phase corrosion inhibitors, and a thixotropic thickener, these coatings enhance barrier and surface protection properties. They can be applied via brush, spray, dip, or roll and are primarily utilized on bare metal
Bakeware Market | Global Industry Size, Development Strategy, Revenue Analysis, …
The market for bakeware is a dynamic and evolving sector that serves both commercial and residential consumers. In 2023, the bakeware market was valued at $3,850.0 million and is projected to reach $6,462.2 million by the end of 2032. This market is anticipated to grow at a compound annual growth rate (CAGR) of 5.91% during the forecast period from 2024 to 2032. The growth is largely driven by a resurgence
Global Wire Harness Market Set to Expand Through 2032 with Major Growth Drivers …
The global wire harness market is poised for robust growth, with a projected compound annual growth rate (CAGR) of 5.8% from 2024 to 2032. This growth trajectory is primarily driven by significant advancements in the automotive sector, escalating demand within consumer technology, and increasing applications in aerospace and defense sectors. In the automotive industry, the wire harness market has seen substantial growth, primarily fueled by the advent of electric vehicles (EVs)

All 4 Releases


More Releases for Angina

Angina (Angina Pectoris) Pipeline: 10+ Companies Transforming Chest Pain Managem …
The angina therapeutics pipeline is experiencing a renaissance, driven by pharmaceutical companies such as Abbott Laboratories, AstraZeneca, Bayer AG, and Bristol-Myers Squibb. With a focus on improving myocardial efficiency and reducing ischemic burden, emerging therapies-including metabolic modulators, nitric oxide donors, and gene therapies-aim to offer more effective symptom relief and reduce cardiovascular events. Innovations are targeting both stable and microvascular angina forms, addressing the significant unmet needs in chronic angina
Key Influencer in the Angina Pectoris Drugs Market Outlook 2025: Surging Prevale …
What market dynamics are playing a key role in accelerating the growth of the angina pectoris drugs market? The surge in cardiovascular diseases is anticipated to kick-start the expansion of the angina pectoris drug market. The scope of cardiovascular diseases includes diverse disorders affecting the heart and blood vessels, such as stroke, coronary artery disease, hypertension, and heart failure. The rising prevalence of cardiovascular diseases (CVD) is linked to numerous elements,
What's Driving the Angina Market 2025-2034: The Rising Prevalence of Coronary Ar …
What Are the Projections for the Size and Growth Rate of the Angina Market? The scale of the angina market has seen robust growth in the previous years. The expansion is expected to continue, increasing from a value of $10.71 billion in 2024 to $11.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The surge in the past period can be credited to factors such as a
Angina Pectoris - Drug Pipeline Landscape, 2022
Global Angina Pectoris Market report from Global Insight Services is the single authoritative source of intelligence on angina pectoris market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,
Angina Pectoris - Drug Pipeline Landscape, 2022
Angina also known as angina pectoris, is a type of chest pain or discomfort that occurs when a part of the heart doesn't get enough blood and oxygen, which is due to the spasm or obstruction of the arteries that supply the blood to the heart muscles. Angina is mainly of four types: stable angina, unstable angina, microvascular angina, and vasospastic or variant angina. Angina is caused due to the built
Angina Pectoris Drugs Market Set for Rapid Growth
Global Angina Pectoris Drugs Market: Overview The demand within the global market for angina pectoris drugs has been rising on account of the focus given on treating medical conditions suffered by the geriatric population. The presence of a seamless industry for healthcare diagnostic and treatment has played a major role in market growth. Angina pectoris is a type of chest pain that is triggered due to reduced blood flow to